BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29278547)

  • 21. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.
    Ighodaro I; Eric OK; Adebayo O
    Niger J Physiol Sci; 2013 Dec; 28(2):127-33. PubMed ID: 24937386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity.
    Hou X; Shen YH; Li C; Wang F; Zhang C; Bu P; Zhang Y
    Biochem Biophys Res Commun; 2010 Apr; 394(3):653-9. PubMed ID: 20226762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.
    Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y
    Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.
    Rubattu S; Cotugno M; Bianchi F; Sironi L; Gelosa P; Stanzione R; Forte M; De Sanctis C; Madonna M; Marchitti S; Pignieri A; Sciarretta S; Volpe M
    J Hypertens; 2017 Sep; 35(9):1857-1871. PubMed ID: 28399045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.
    Rubattu S; Stanzione R; Bianchi F; Cotugno M; Forte M; Della Ragione F; Fioriniello S; D'Esposito M; Marchitti S; Madonna M; Baima S; Morelli G; Sciarretta S; Sironi L; Gelosa P; Volpe M
    Cell Death Dis; 2017 Jun; 8(6):e2891. PubMed ID: 28640254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
    Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
    Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
    Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
    Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits.
    Balakumar P; Sambathkumar R; Mahadevan N; Muhsinah AB; Alsayari A; Venkateswaramurthy N; Dhanaraj SA
    Pharmacol Res; 2019 Jun; 144():132-141. PubMed ID: 30970278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
    Wilson TW; Alonso-Galicia M; Roman RJ
    Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains.
    Rubattu S; Bianchi F; Busceti CL; Cotugno M; Stanzione R; Marchitti S; Di Castro S; Madonna M; Nicoletti F; Volpe M
    Oncotarget; 2015 Aug; 6(22):18800-18. PubMed ID: 26023797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex- and age-related differences in renal and cardiac injury and senescence in stroke-prone spontaneously hypertensive rats.
    Ansari A; Walton SL; Denton KM
    Biol Sex Differ; 2023 May; 14(1):33. PubMed ID: 37217968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
    Zuo N; Zheng X; Liu H; Ma X
    Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys.
    Wang M; Wang L; Zhou L; Xu Y; Wang C
    Phytomedicine; 2024 Apr; 126():155450. PubMed ID: 38368794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane A
    Nagatani Y; Higashino T; Kinoshita K; Higashino H
    Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1391-1401. PubMed ID: 34152603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat.
    Ovcharenko E; Hansen MK; Goltsman I; Abu-Saleh N; Abassi Z; Walsh K; Miele G; Feuerstein GZ; Winaver J
    Nephron Physiol; 2010; 115(3):p21-30. PubMed ID: 20460939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary fish oil prevents the development of renal damage in salt-loaded stroke-prone spontaneously hypertensive rats.
    Hobbs LM; Rayner TE; Howe PR
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):508-13. PubMed ID: 8800575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
    Ogata T; Miyauchi T; Irukayama-Tomobe Y; Takanashi M; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S279-82. PubMed ID: 15838301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
    Jen HL; Yin WH; Chen JW; Lin SJ
    J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.